Acorda Therapeutics, Inc. (ACOR) Income Annual - Discounting Cash Flows
ACOR
Acorda Therapeutics, Inc.
ACOR (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-30
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
Report Filing 2024-05-14 2024-04-01 2023-03-15 2022-03-18 2021-03-16 2020-02-28 2019-02-27 2018-03-01 2017-02-27 2016-02-29 2015-02-27 2014-03-03 2013-02-28 2012-02-28 2011-03-01 2010-02-26 2009-03-02 2008-03-14 2007-03-26 2006-03-31 2004-12-31 2003-12-31
Revenue 115.7 117.6 118.6 129.1 153 192.4 471.4 588.3 519.6 492.7 401.5 336.4 305.8 292.2 191 54.67 47.83 39.49 27.35 5.15 0.479 0.856
Cost of Revenue 23.45 46.05 30.33 40.79 33.51 34.85 99.31 135.7 108.1 92.93 80.61 66.64 57.64 66.57 35.52 11.39 11.35 8.36 7.12 5.13 5.3 0
Gross Profit 92.22 71.59 88.23 88.28 119.5 157.6 372.1 452.6 411.5 399.7 320.9 269.8 248.2 225.7 155.5 43.28 36.47 31.13 20.23 0.013 -4.82 0.856
Operating Expenses 116.5 94.85 130.3 165.6 206.4 143 333.6 685.4 447.5 365.7 284.5 239.4 222.6 190.6 163.9 124.5 109.9 70.58 43.7 34.42 39.94 63.34
Research & Development 4.72 5.15 5.8 10.42 23.01 60.08 106.4 166.1 203.4 149.2 73.47 53.88 53.88 42.11 30.6 34.61 36.6 22.41 12.05 12.89 22 34.27
Selling, General and Administrative 95.55 89.7 106.3 124.4 152.6 192.8 172.3 181.3 217.9 205.6 201.8 185.5 168.7 148.5 133.3 89.93 73.31 48.17 31.64 21.53 17.95 0
Other Operating Expenses 16.24 0 18.21 30.76 30.76 -109.9 55 338 26.15 10.9 9.19 0 0 0 0 0 0 0 0 0 0 29.07
Operating Income -24.3 -23.26 -42.04 -77.3 -86.9 14.55 38.49 -232.8 -35.98 33.99 36.39 30.36 25.6 35.05 -8.43 -81.26 -73.44 -39.45 -23.47 -34.41 -44.77 -62.48
Net Non-Operating Interest -32.16 -31 -26.38 -30.03 -29.76 -17.7 -18.08 -18.53 -16.19 -15.03 -8.61 -1.5 -1.33 -3.02 -3.35 -2.67 0 0 0 0 0 0
Interest Income 0.644 0.53 1.91 0.005 0.816 4.17 3.52 0.136 0.339 0.44 0.674 0.668 0.552 0.552 0.575 1.75 0 0 0 0 0 0
Interest Expense 32.8 31.53 28.29 30.04 30.57 21.87 21.6 18.66 16.53 15.47 9.29 2.17 1.88 3.57 3.92 4.41 0 0 0 0 0 0
Equity & Other Income/(Expense) -248 -241.8 33.17 -1.75 8.99 -271.1 0.016 -0.543 9.9 0.411 0.232 0 -0.006 -0.018 0.008 -0.017 0.008 0.051 0.075 0.001 0.002 -0.636
Income Before Tax -304.4 -296 -35.25 -109.1 -107.7 -274.2 20.42 -251.9 -42.27 19.37 28.01 28.86 24.27 32.02 -11.77 -83.94 -73.43 -39.4 -23.39 -34.41 -44.76 -63.12
Income Tax Expense -41.02 -43.17 30.67 -5.12 -8.07 -1.28 -13.26 -28.53 -6.67 8.31 10.34 12.42 -130.7 1.41 -0.591 -1.73 0.893 -0.869 0.477 1.12 -0.029 -0.033
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 -0.985 0 0 0 0 0 0.59 1.73 0.016 -0.553 0.151 0.002 0.005 -0.636
Net Income -263.4 -252.9 -65.92 -104 -99.59 -273 33.68 -223.4 -34.62 11.06 17.67 16.44 155 30.61 -11.77 -83.94 -74.34 -37.97 -24.02 -35.53 -44.74 -62.45
Depreciation and Amortization 24.19 31.67 32.01 32.5 21.94 25.64 11.48 23.23 21.58 15.01 8.47 7 4.66 4.62 3.95 7.69 0.446 -0.655 1.58 1.81 3.07 0.636
EBITDA -0.111 8.4 -10.03 -44.8 -64.95 40.18 49.97 -209.6 -14.4 49 44.86 37.36 30.27 39.68 -4.48 -73.57 -72.99 -40.1 -21.88 -32.6 -41.7 -61.84
Earnings Per Share (EPS) -262.6 -203.6 -66.9 -195.8 -246.4 -689.4 85.98 -582.7 -91.79 31.42 51.53 49.07 471.2 93.6 -36.82 -266.9 -262.9 -173.7 -157.1 -20,851 -27,182 -38,835
Diluted Earnings Per Share -262.6 -203.6 -66.9 -195.8 -246.4 -689.4 85.38 -583.2 -91.79 30 50.4 46.8 460.8 91.2 -36.82 -266.9 -262.9 -173.7 -157.1 -20,851 -27,182 -38,835
Weighted Average Shares Outstanding 1.24 1.24 0.985 0.531 0.404 0.396 0.392 0.383 0.377 0.364 0.351 0.347 0.336 0.325 0.32 0.314 0.283 0.219 0.153 0.002 0.002 0.002
Diluted Weighted Average Shares Outstanding 1.24 1.24 0.985 0.531 0.404 0.396 0.395 0.383 0.377 0.369 0.355 0.351 0.336 0.334 0.32 0.314 0.283 0.219 0.153 0.002 0.002 0.002
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program